Defense and Aerospace Demand ARQUIMEA operates in aerospace, defense, science, and fintech, with recent launches in naval loitering munitions (Kronos Mini) and autonomous naval systems, plus an air defense C-UAS system. Potential sales opportunities exist in advanced weapon systems, counter-UAS, naval robotics, and surveillance/defense tech for both government and defense contractors.

Global Reach Active in 40 countries and with a history since 2005, ARQUIMEA has established international exposure and customer proximity. Sales opportunities include multi-regional deployments, international partnerships, and managed services or training programs to support global operations.

Innovative R&D Reinvestment The company reinvests most profits into innovative solutions, signaling strong investment in R&D across advanced technologies such as teleoperation, robotics, digital twins, and AI. This suggests openness to long-term collaboration, co-development deals, and funded research initiatives.

Technology Stack and Platforms Utilizes Docker, cloud platforms (Google Cloud, Azure), NetSuite, Jira, SonarQube and AI tools (Claude by Anthropic). This indicates and enables scalable software, data analytics, cloud-enabled solutions, and lifecycle management—opportunities for site reliability engineering services, cloud migrations, and DevOps/QA service offerings.

Strategic Partnerships and Spin-offs Recent spin-off activity (Molefy Pharma) and participation in major events (DSEI, Eurosatory, ICRA) show a trajectory of expanding capabilities and market presence. Opportunities exist in collaborating for dual-use technologies, contract manufacturing support, and entering adjacent markets through alliances.